Development of a Rat Model for Evaluating Thyroid-Stimulating Hormone Suppression after Total Thyroidectomy.

Area of Science:

• Endocrinology
• Surgical Research
• Animal Models

Background:

• Thyroid-stimulating hormone (TSH) suppression therapy is crucial after total thyroidectomy.
• Developing reliable animal models is essential for evaluating such therapies.
• This study aimed to establish a rat model for TSH suppression therapy assessment.

Purpose of the Study:

• To develop and validate a rat model for evaluating TSH suppression therapy post-thyroidectomy.
• To determine optimal L-thyroxine (L-T4) dosage for TSH suppression in this model.

Main Methods:

• Sixty Wistar rats underwent total thyroidectomy or sham operation.
• Rats received varying doses of L-T4 (1.4-2.0 μg/100 g body weight) post-thyroidectomy.
• Histological examination and serum hormone levels (T3, T4, TSH) were analyzed.

Main Results:

• Histology confirmed complete thyroid gland resection with no residual tissue in treated groups.
• The L-T4 dose of 1.6 μg/100 g body weight (TS-II group) achieved serum T3 levels comparable to controls.
• This dose resulted in slightly elevated T4 and slightly suppressed TSH levels, indicating effective suppression.

Conclusions:

• A rat model using L-T4 at 1.6 μg/100 g body weight for 15 days post-thyroidectomy is suitable for TSH suppression therapy studies.
• This model provides a valuable tool for preclinical research in thyroid cancer management and hormone replacement therapy.